Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 5Fallopian Tube Neoplasms 5Breast Neoplasms 5Endometrial Neoplasms 4Neoplasms 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Carcinoma, Ovarian Epithelial 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Solid Tumor, Unspecified, Adult 1Solid Tumor 1Small Cell Lung Carcinoma 1Prostate Cancer Metastatic 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Metastatic Castration-resistant Prostate Cancer 1Mesothelioma, Malignant 1Leiomyosarcoma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1Adenocarcinoma, Clear Cell 1Adenocarcinoma of the Oesophagus 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1ATM Gene Mutation 1

Interventions

rucaparib 1Tomography, X-Ray Computed 1Irinotecan 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Solid Tumor, Unspecified, Adult × rucaparib × Clear all
NCT03318445 2021-03-04

Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair

University of California, San Francisco

Phase 1 Completed
22 enrolled
Other solid neoplasm

Solid Tumor, Unspecified, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡